Big Picture Retirement

Advances in predictive medicine are starting to raise a fascinating question: what if we could estimate our longevity with much greater accuracy? New blood tests and biomarkers are being developed that may help identify risks for diseases years—or even decades—before symptoms appear. Some researchers believe these tools could eventually provide meaningful clues about how long we might live. If that happens, it could have major implications for retirement planning. Should information about your potential lifespan influence when you retire, how much you spend, or how you invest? In this episode, we explore how predictive medicine is evolving, what scientists are learning from advanced blood testing, and whether this kind of information could one day reshape how people plan for retirement. Although this show does not provide specific tax, legal, or financial advice, you can engage Devin or John through their individual firms.